| Pamela Paige Hayes, MD | |
|
7777 Forest Ln Ste 400, Dallas, TX 75230-2571 | |
| (972) 566-7790 | |
| (972) 566-5819 |
| Full Name | Pamela Paige Hayes |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 10 Years |
| Location | 7777 Forest Ln Ste 400, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023437290 | NPI | - | NPPES |
| 418022601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | S5641 (Texas) | Secondary |
| 207RX0202X | Internal Medicine - Medical Oncology | S5649 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Dallas Hospital | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
Researchers at University of California San Diego School of Medicine, Texas A&M College of Medicine and the Omni-Net Birth Defects Prevention Program in Ukraine have identified a blood test that may help predict how severely a baby will be affected by alcohol exposure during pregnancy, according to a study published November 9 in the journal PLOS ONE.
Fewer adolescents in Utah get vaccinated than their counterparts in other states, and Utah women receive fewer screenings for breast, colorectal and cervical cancer compared with women nationwide, according to findings released Thursday at the State of Our Health program forum, the Salt Lake Tribune reports.
Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of patients into its pivotal Phase 3 programme of ST10 for the treatment of iron-deficient anaemia. ST10 is a novel form of ferric iron taken orally.
Nice to meet you! Skin cancer can come at any time so it's important to remember to check your moles regularly. I don't mean moles like me, but the ones on your body.
US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).
› Verified 8 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
Researchers at University of California San Diego School of Medicine, Texas A&M College of Medicine and the Omni-Net Birth Defects Prevention Program in Ukraine have identified a blood test that may help predict how severely a baby will be affected by alcohol exposure during pregnancy, according to a study published November 9 in the journal PLOS ONE.
Fewer adolescents in Utah get vaccinated than their counterparts in other states, and Utah women receive fewer screenings for breast, colorectal and cervical cancer compared with women nationwide, according to findings released Thursday at the State of Our Health program forum, the Salt Lake Tribune reports.
Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of patients into its pivotal Phase 3 programme of ST10 for the treatment of iron-deficient anaemia. ST10 is a novel form of ferric iron taken orally.
Nice to meet you! Skin cancer can come at any time so it's important to remember to check your moles regularly. I don't mean moles like me, but the ones on your body.
US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pamela Paige Hayes, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Pamela Paige Hayes, MD 7777 Forest Ln Ste 400, Dallas, TX 75230-2571 Ph: (972) 566-7790 |
News Archive
Researchers at University of California San Diego School of Medicine, Texas A&M College of Medicine and the Omni-Net Birth Defects Prevention Program in Ukraine have identified a blood test that may help predict how severely a baby will be affected by alcohol exposure during pregnancy, according to a study published November 9 in the journal PLOS ONE.
Fewer adolescents in Utah get vaccinated than their counterparts in other states, and Utah women receive fewer screenings for breast, colorectal and cervical cancer compared with women nationwide, according to findings released Thursday at the State of Our Health program forum, the Salt Lake Tribune reports.
Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of patients into its pivotal Phase 3 programme of ST10 for the treatment of iron-deficient anaemia. ST10 is a novel form of ferric iron taken orally.
Nice to meet you! Skin cancer can come at any time so it's important to remember to check your moles regularly. I don't mean moles like me, but the ones on your body.
US-Australian drug discovery company, Novogen Limited, in conjunction with Australian paediatric cancer researchers, released key pre-clinical data on experimental cancer drug-candidate, TRXE-009, confirming its potential to become an important new therapy against an incurable paediatric brain cancer called DIPG (diffuse intrinsic pontine glioma).
› Verified 8 days ago
Uma B.r.k Pakkivenkata, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |